Skip to Content

Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2839 Logo 2839

Fenofibric acid delayed-release 135 mg Logo 2839 Logo 2839

Fenofibric Acid Delayed-Release

Imprint
Logo 2839 Logo 2839
Strength
135 mg
Color
Brown & Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-2839
Inactive Ingredients
ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, hydroxypropyl cellulose (type l), sodium lauryl sulfate, sucrose, corn starch, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.